Patient with repeated cerebral vascular occlusion receive three thrombolysis and two endovascular treatments within 103 hours: a case report

Restoring blood flow through intravenous thrombolysis (IVT) or endovascular treatment (EVT) is the most effective therapy for acute ischemic stroke (AIS). However, reocclusion remains a common complication in patients who achieve successful revascularization. Currently, there is no recommendation for the treatment of reocclusion in the guidelines for stroke. Antiplatelet and anticoagulant drugs, repeated IVT (rIVT) and repeated EVT (rEVT) can be considered. We present a case of an AIS patient who underwent three IVTs and two EVTs. A 59-year-old man with AIS manifesting as recurrent reocclusion of the left internal carotid artery received three IVTs and two EVTs within 103 h and eventually achieved a good outcome. During the treatment, tirofiban and heparin were administrated for antithrombotic therapy. rIVT and rEVT may be viable for patients with early recurrent reocclusion after a full evaluation. This case report highlights the potential efficacy and safety of multiple revascularization therapy in a short period.

Authors

Institutions

Publication Details

Journal
BMC Neurology
Published
2026-08-28
DOI
https://doi.org/10.1186/s12883-026-05334-1
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient with repeated cerebral vascular occlusion receive three thrombolysis and two endovascular treatments within 103 hours: a case report

Chengchun Liu, Meng Zhang, Yi Yang, Zhi-Qiang Sun et al.
BMC Neurology
Acute Ischemic Stroke Management
article

Patient with repeated cerebral vascular occlusion receive three thrombolysis and two endovascular treatments within 103 hours: a case report

Chengchun Liu, Meng Zhang, Yi Yang, Zhi-Qiang Sun, Wang-Sheng Jin
article en

Abstract

Restoring blood flow through intravenous thrombolysis (IVT) or endovascular treatment (EVT) is the most effective therapy for acute ischemic stroke (AIS). However, reocclusion remains a common complication in patients who achieve successful revascularization. Currently, there is no recommendation for the treatment of reocclusion in the guidelines for stroke. Antiplatelet and anticoagulant drugs, repeated IVT (rIVT) and repeated EVT (rEVT) can be considered. We present a case of an AIS patient who underwent three IVTs and two EVTs. A 59-year-old man with AIS manifesting as recurrent reocclusion of the left internal carotid artery received three IVTs and two EVTs within 103 h and eventually achieved a good outcome. During the treatment, tirofiban and heparin were administrated for antithrombotic therapy. rIVT and rEVT may be viable for patients with early recurrent reocclusion after a full evaluation. This case report highlights the potential efficacy and safety of multiple revascularization therapy in a short period.

BMC Neurology
Army Medical University (CN), Daping Hospital (CN), Pingjin Hospital (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 10%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Patient with repeated cerebral vascular occlusion receive three thrombolysis and two endovascular treatments within 103 hours: a case report — Chengchun Liu, Meng Zhang, et al. · BMC Neurology (2026) | TGRS Research Map | TGRS